InvestorsHub Logo

k7777

10/14/15 3:26 PM

#57903 RE: RVC #57900

If it's dilution then we can't help this stock but if traders not interested any more it's not going to stop this product or stock, I am in this field for 14 years not in stock but treat patient who is in pain, this product is amazing cheap any one can afford different then so many different products in market, my friends who's in medical profession more then 10 years in uk they really like this product and very good response from their patient, just think u can use at any where any time without knowing any body helps u to relive pain. If this product gets clearance for OTC we are going to rock.

My opinion.

seven-up

10/14/15 3:52 PM

#57914 RE: RVC #57900

So if a $50 Million licensing agreement is signed, would that change anything, related to BIEL? This has been discussed by the CEO
Andy.....

RVC

10/14/15 4:00 PM

#57920 RE: RVC #57900

Not benefit shareholders, pay family debt with near term revenue influx. Dilution has to be reversed and records indicate no plan to change current course, If there was confidence in near term revenue stream, would not be filing documents to increase shares